This document is a correction notice for an article titled "A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer" published in BMC Cancer. The correction addresses a typesetting error in the equal contributions statement, clarifying that Weiwei Huang and Chenxi Wang contributed equally to the work. The original article has been corrected. The publisher, Springer Nature, maintains a neutral stance on jurisdictional claims and institutional affiliations. The authors of the article are listed as Weiwei Huang, Chenxi Wang, Yangkun Shen, Qi Chen, Zhijian Huang, Jian Liu, Xiaoyan Lin, Lili Wang, Fan Wu, Xinhua Chen, Nani Li, Yi Hong, Mulan Chen, Jieyu Li, and Chuanzhong Huang. [Extracted from the article]